These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3970557)

  • 1. [Effect of human recombinant beta-interferon on natural killer activity of peripheral lymphocytes in cancer patients].
    Beika T; Tanaka N; Yamada J; Hizuta A; Onishi K; Akura Y; Hirose K; Orita K
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):362-5. PubMed ID: 3970557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of human recombinant-gamma interferon on the immune function of peripheral blood lymphocytes in cancer patients].
    Yamada J; Tanaka N; Kamitani S; Goto K; Gangi J; Orita K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1946-52. PubMed ID: 2939802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
    Okabe M; Gomi K; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
    Yoon SJ; Heo DS; Kang SH; Lee KH; Kim WS; Kim GP; Lee JA; Lee KS; Bang YJ; Kim NK
    Anticancer Res; 1998; 18(3A):1591-6. PubMed ID: 9673375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distribution of lymphocyte subpopulation and natural killer activity in gastric cancer tissue, normal stomach and various tissues of gastric cancer patients].
    Moritani Y
    Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):132-42. PubMed ID: 6611484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
    Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
    Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
    Yasunaga Y; Nishimura K; Miura H; Takatera H; Kuroda H; Kishimoto T; Fujioka H
    Hinyokika Kiyo; 1995 Feb; 41(2):85-92. PubMed ID: 7702012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-enhancing effect of recombinant human interferon-beta produced in Escherichia coli on human peripheral blood mononuclear cells in vitro.
    Okabe M; Morimoto M; Nakamizo N
    Gan; 1983 Oct; 74(5):743-50. PubMed ID: 6357933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period.
    Lister J; Rybka WB; Donnenberg AD; deMagalhaes-Silverman M; Pincus SM; Bloom EJ; Elder EM; Ball ED; Whiteside TL
    Clin Cancer Res; 1995 Jun; 1(6):607-14. PubMed ID: 9816022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
    J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Natural killer (NK) activity of the peripheral blood lymphocytes in cancer patients].
    Song Y
    Zhonghua Wai Ke Za Zhi; 1989 Jun; 27(6):357-8, 381-2. PubMed ID: 2479505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of CDDP administration on NK activity of human peripheral lymphocytes and its modification by corticosteroid as anti-emetic agent].
    Takahashi K; Saijo N; Seki S; Kimata M; Sasaki Y; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Hoshi A
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):492-6. PubMed ID: 6538405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase I-II study of recombinant interleukin-2].
    Sano T; Saijo N; Sasaki Y; Shinkai T; Eguchi K; Tamura T; Sakurai M; Takahashi H; Nakano H; Nakagawa K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):903-13. PubMed ID: 3494427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local administration of recombinant interferon-beta to patients with cancer-associated body cavity fluids].
    Tanaka N; Terasawa A; Matsui T; Yamada J; Hizuta A; Ichikawa J; Nakayama F; Matsuda T; Orita K
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):237-41. PubMed ID: 3341785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of low doses of alpha interferon in patients with breast cancer.
    Laszlo J; Hood L; Cox E; Goodwin B
    J Biol Response Mod; 1986 Jun; 5(3):206-10. PubMed ID: 3723137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of regulatory T cells in the peripheral blood of cancer patients.
    Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B
    Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients.
    Koren HS; Brandt CP; Tso CY; Laszlo J
    J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.